Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,3,8-trihydroxy-6-hydroxymethylanthraquinone
2. Omega-hydroxyemodin
1. Omega-hydroxyemodin
2. 481-73-2
3. 1,3,8-trihydroxy-6-(hydroxymethyl)anthracene-9,10-dione
4. .omega.-hydroxyemodin
5. 1,3,8-trihydroxy-6-hydroxymethylanthraquinone
6. W-hydroxyemodin
7. 9,10-anthracenedione, 1,3,8-trihydroxy-6-(hydroxymethyl)-
8. Chebi:81348
9. 1,3,8-trihydroxy-6-(hydroxymethyl)anthra-9,10-quinone
10. Chembl290932
11. O2h2z421ap
12. Nsc624612
13. Nsc-624612
14. 1,3,8-trihydroxy-6-(hydroxymethyl)-9,10-dihydroanthracene-9,10-dione
15. Anthraquinone, 1,3,8-trihydroxy-6-(hydroxymethyl)-hydroxyemodin; Nsc 624612; Omega-hydroxyemodin
16. Ccris 1319
17. Unii-o2h2z421ap
18. Hydroxyemodin
19. Hydroxyemodin, .omega.-
20. Schembl18048123
21. Acon1_001349
22. Gtpl11005
23. Dtxsid60197420
24. Zinc5812872
25. Bdbm50020376
26. Akos028108661
27. Ncgc00180600-01
28. C17810
29. F21513
30. 3-(4-tert-butyl-phenoxy)-benzyl-hydrazine
31. Brd-k95337480-001-01-4
32. Q27155287
33. 1,3,8-trihydroxy-6-(hydroxymethyl)anthraquinone
34. 1,3,8-trihydroxy-6-(hydroxymethyl)-9,10-anthracenedione
35. Anthraquinone, 1,3,8-trihydroxy-6-(hydroxymethyl)-
| Molecular Weight | 286.24 g/mol |
|---|---|
| Molecular Formula | C15H10O6 |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 1 |
| Exact Mass | 286.04773803 g/mol |
| Monoisotopic Mass | 286.04773803 g/mol |
| Topological Polar Surface Area | 115 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 449 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A omega-Hydroxyemodin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of omega-Hydroxyemodin, including repackagers and relabelers. The FDA regulates omega-Hydroxyemodin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. omega-Hydroxyemodin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A omega-Hydroxyemodin supplier is an individual or a company that provides omega-Hydroxyemodin active pharmaceutical ingredient (API) or omega-Hydroxyemodin finished formulations upon request. The omega-Hydroxyemodin suppliers may include omega-Hydroxyemodin API manufacturers, exporters, distributors and traders.
omega-Hydroxyemodin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of omega-Hydroxyemodin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right omega-Hydroxyemodin GMP manufacturer or omega-Hydroxyemodin GMP API supplier for your needs.
A omega-Hydroxyemodin CoA (Certificate of Analysis) is a formal document that attests to omega-Hydroxyemodin's compliance with omega-Hydroxyemodin specifications and serves as a tool for batch-level quality control.
omega-Hydroxyemodin CoA mostly includes findings from lab analyses of a specific batch. For each omega-Hydroxyemodin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
omega-Hydroxyemodin may be tested according to a variety of international standards, such as European Pharmacopoeia (omega-Hydroxyemodin EP), omega-Hydroxyemodin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (omega-Hydroxyemodin USP).
LOOKING FOR A SUPPLIER?
